Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.
2.

A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism.

Fennerty AG, Dolben J, Thomas P, Backhouse G, Bentley DP, Campbell IA, Routledge PA.

Clin Lab Haematol. 1987;9(1):17-21.

PMID:
3581712
[PubMed - indexed for MEDLINE]
3.

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.

PMID:
11369685
[PubMed - indexed for MEDLINE]
Free Article
5.

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ.

BMJ. 2007 Mar 31;334(7595):674. Epub 2007 Feb 8.

PMID:
17289685
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study.

Monreal M, Lafoz E, Ruiz J, Callejas JM, Arias A.

Eur J Vasc Surg. 1994 Sep;8(5):584-9.

PMID:
7813725
[PubMed - indexed for MEDLINE]
7.

Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.

Carter BL, Jones ME, Waickman LA.

Clin Pharm. 1985 May-Jun;4(3):279-96. Review.

PMID:
3891200
[PubMed - indexed for MEDLINE]
8.

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.

PMID:
17296569
[PubMed - indexed for MEDLINE]
Free Article
9.

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.

N Engl J Med. 1997 Feb 6;336(6):393-8.

PMID:
9010144
[PubMed - indexed for MEDLINE]
Free Article
10.

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.

Arch Intern Med. 1998 Sep 14;158(16):1809-12.

PMID:
9738611
[PubMed - indexed for MEDLINE]
11.

Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.

Bullano MF, Willey V, Hauch O, Wygant G, Spyropoulos AC, Hoffman L.

J Manag Care Pharm. 2005 Oct;11(8):663-73.

PMID:
16194130
[PubMed - indexed for MEDLINE]
Free Article
12.

Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.

Hyers TM, Spyropoulos AC; INNOVATE Investigators.

J Thromb Thrombolysis. 2007 Dec;24(3):225-32. Epub 2007 Mar 3.

PMID:
17334932
[PubMed - indexed for MEDLINE]
13.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
[PubMed - indexed for MEDLINE]
14.

Deep venous thrombosis. Implications after open heart surgery.

DeLaria GA, Hunter JA.

Chest. 1991 Feb;99(2):284-8.

PMID:
1989784
[PubMed - indexed for MEDLINE]
15.

Current management of acute symptomatic deep vein thrombosis.

Heit JA.

Am J Cardiovasc Drugs. 2001;1(1):45-50. Review.

PMID:
14728051
[PubMed - indexed for MEDLINE]
16.

Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice.

Zidane M, Schram MT, Planken EW, Molendijk WH, Rosendaal FR, van der Meer FJ, Huisman MV.

Arch Intern Med. 2000 Aug 14-28;160(15):2369-73.

PMID:
10927736
[PubMed - indexed for MEDLINE]
17.

The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.

Jiménez D, Díaz G, Marín E, Vidal R, Sueiro A, Yusen RD.

Thromb Haemost. 2006 Mar;95(3):562-6.

PMID:
16525588
[PubMed - indexed for MEDLINE]
18.

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

Clin Ther. 2004 Jul;26(7):1149-59.

PMID:
15336480
[PubMed - indexed for MEDLINE]
19.

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H.

N Engl J Med. 1995 Jun 22;332(25):1661-5.

PMID:
7760866
[PubMed - indexed for MEDLINE]
Free Article
20.

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al.

Thromb Haemost. 1995 Aug;74(2):606-11.

PMID:
8584992
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk